Studying cancer in pet dogs to find new treatments for human patients

Oct 13, 2009

A team of scientists at the National Cancer Institute (NCI) in Bethesda, USA, says that studying pet dogs with cancer could yield valuable information on how to diagnose and treat human cancers. In this week's PLoS Medicine, the team discusses an ongoing initiative in which spontaneously occurring cancers in dogs are being studied to help inform the development of new cancer drugs, devices and imaging strategies for human cancer patients.

Estimates suggest that as many as 1 million new diagnoses of cancer occur in in the United States each year. The condition is treated much like human cancer, with surgery, radiation, and chemotherapy. owners are often motivated to pursue novel and investigational treatments with their veterinarians.

The team of scientists at the Centre for Cancer Research at the NCI, led by Dr. Chand Khanna, believes that studying these new therapies in clinical trials with dogs may yield insights into how to improve care for human patients. Naturally occurring tumors in dogs have clinical and biological similarities to the human disease.

Khanna and colleagues say that a pet owner's decision to pursue an experimental therapy is influenced by a number of factors, especially the possible risks and benefits of the new therapy and the reduced costs for care provided by the investigational trial.

Additionally, they say, "many pet owners are motivated by the opportunity to contribute to the advancement of cancer treatment for future human and canine patients."

The study of and treatment in animals with naturally occurring cancers, known as comparative oncology, is not a new concept. Over the last 30-40 years investigators have used this approach to advance understanding and treatment of several human cancers, such as (osteosarcoma), lymphoma, and melanoma.

More information: Gordon I, Paoloni M, Mazcko C, Khanna C (2009) The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Drug Development Pathway. PLoS Med 6(10): e1000161. doi:10.1371/journal.pmed.1000161

Source: Public Library of Science

Explore further: Small increase in cancer risk following CT scans in childhood and adolescence

add to favorites email to friend print save as pdf

Related Stories

Cancer cures could work for canines and humans

Jul 12, 2007

One of the major issues associated with longer life expectancy in man and his best friend is an increase in the incidence of cancer. Even though they cannot talk it seems dogs might be able to tell us why and how certain ...

Recommended for you

Beta-blockers may boost chemo effect in childhood cancer

3 hours ago

Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Jo ...

Changing cancer's environment to halt its spread

18 hours ago

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

User comments : 0

More news stories

How healthy are you for your age?

On May 22, JoVE will publish details of a technique to measure the health of human genetic material in relation to a patient's age. The method is demonstrated by the laboratory of Dr. Gil Atzmon at New York's Albert Einste ...

Addiction as a disorder of decision-making

New research shows that craving drugs such as nicotine can be visualized in specific regions of the brain that are implicated in determining the value of actions, in planning actions and in motivation. Dr. Alain Dagher, from ...

Study says empathy plays a key role in moral judgments

Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...